Page 70 - Read Online

Page 18 of 19 Masiero et al. Mini-invasive Surg 2022;6:4 https://dx.doi.org/10.20517/2574-1225.2021.104

67. Lanz J, Kim W, Walther T, et al. Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter
aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial. Lancet 2019;394:1619-
28. DOI PubMed
68. Mauri V, Kim WK, Abumayyaleh M, et al. Short-term outcome and hemodynamic performance of next-generation self-expanding
versus balloon-expandable transcatheter aortic valves in patients with small aortic annulus: a multicenter propensity-matched
comparison. Circ Cardiovasc Interv 2017;10:e005013. DOI PubMed
69. Debry N, Sudre A, Amr G, et al. Transcatheter aortic valve implantation for paradoxical low-flow low-gradient aortic stenosis patients.
Catheter Cardiovasc Interv 2016;87:797-804. DOI PubMed
70. Ribeiro HB, Webb JG, Makkar RR, et al. Predictive factors, management, and clinical outcomes of coronary obstruction following
transcatheter aortic valve implantation: insights from a large multicenter registry. J Am Coll Cardiol 2013;62:1552-62. DOI PubMed
71. Nai Fovino L, Scotti A, Massussi M, et al. Incidence and feasibility of coronary access after transcatheter aortic valve replacement.
Catheter Cardiovasc Interv 2020;96:E535-41. DOI PubMed
72. Nai Fovino L, Scotti A, Massussi M, et al. Coronary angiography after transcatheter aortic valve replacement (TAVR) to evaluate the
risk of coronary access impairment after TAVR-in-TAVR. J Am Heart Assoc 2020;9:e016446. DOI PubMed PMC
73. Fontana GP, Bedogni F, Groh M, et al. Safety profile of an intra-annular self-expanding transcatheter aortic valve and next-generation
low-profile delivery system. JACC Cardiovasc Interv 2020;13:2467-78. DOI PubMed
74. van Gils L, Tchetche D, Latib A, et al. TAVI with current CE-marked devices: strategies for optimal sizing and valve delivery.
EuroIntervention 2016;12:Y22-7. DOI PubMed
75. Reardon MJ, Van Mieghem NM, Popma JJ, et al; SURTAVI Investigators. Surgical or transcatheter aortic-valve replacement in
intermediate-risk patients. N Engl J Med 2017;376:1321-31. DOI PubMed
76. Mack MJ, Leon MB, Thourani VH, et al; PARTNER 3 Investigators. Transcatheter aortic-valve replacement with a balloon-
expandable valve in low-risk patients. N Engl J Med 2019;380:1695-705. DOI PubMed
77. Brouwer J, Nijenhuis VJ, Delewi R, et al. Aspirin with or without clopidogrel after transcatheter aortic-valve implantation. N Engl J
Med 2020;383:1447-57. DOI PubMed
78. Nijenhuis VJ, Brouwer J, Delewi R, et al. Anticoagulation with or without clopidogrel after transcatheter aortic-valve implantation. N
Engl J Med 2020;382:1696-707. DOI PubMed
79. Dangas GD, Tijssen JGP, Wöhrle J, et al; GALILEO Investigators. A controlled trial of rivaroxaban after transcatheter aortic-valve
replacement. N Engl J Med 2020;382:120-9. DOI PubMed
80. Ten Berg J, Sibbing D, Rocca B, et al. Management of antithrombotic therapy in patients undergoing transcatheter aortic valve
implantation: a consensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous
Cardiovascular Interventions (EAPCI), in collaboration with the ESC Council on Valvular Heart Disease. Eur Heart J 2021;42:2265-9.
DOI PubMed
81. Katz M, Carlos Bacelar Nunes Filho A, Caixeta A, et al; Brazilian TAVI Registry investigators. Gender-related differences on short-
and long-term outcomes of patients undergoing transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2017;89:429-36.
DOI PubMed
82. Romano S, Buccheri S, Mehran R, Angiolillo DJ, Capodanno D. Gender differences on benefits and risks associated with oral
antithrombotic medications for coronary artery disease. Expert Opin Drug Saf 2018;17:1041-52. DOI PubMed
83. Nagao K, Taniguchi T, Morimoto T, et al; CURRENT AS Registry Investigators. Anemia in patients with severe aortic stenosis. Sci
Rep 2019;9:1924. DOI PubMed PMC
84. Nicolas J, Claessen BE, Cao D, et al. Preprocedural anemia in females undergoing transcatheter aortic valve implantation: insights
from the WIN-TAVI registry. Catheter Cardiovasc Interv 2021;97:E704-15. DOI PubMed
85. Bière L, Launay M, Pinaud F, et al. Influence of sex on mortality and perioperative outcomes in patients undergoing TAVR: insights
from the FRANCE 2 registry. J Am Coll Cardiol 2015;65:755-7. DOI PubMed
86. Kodali S, Williams MR, Doshi D, et al. Sex-specific differences at presentation and outcomes among patients undergoing transcatheter
aortic valve replacement: a cohort study. Ann Intern Med 2016;164:377-84. DOI PubMed
87. Sannino A, Szerlip M, Harrington K, Schiattarella GG, Grayburn PA. Comparison of baseline characteristics and outcomes in men
versus women with aortic stenosis undergoing transcatheter aortic valve implantation. Am J Cardiol 2018;121:844-9. DOI PubMed
88. Doshi R, Shlofmitz E, Meraj P. Comparison of outcomes and complications of transcatheter aortic valve implantation in women versus
men (from the national inpatient sample). Am J Cardiol 2018;121:73-7. DOI PubMed
89. Stehli J, Dagan M, Zaman S, et al. Impact of gender on transcatheter aortic valve implantation outcomes. Am J Cardiol 2020;133:98-
104. DOI PubMed
90. Chandrasekhar J, Dangas G, Yu J, et al; STS/ACC TVT Registry. Sex-based differences in outcomes with transcatheter aortic valve
therapy: TVT registry from 2011 to 2014. J Am Coll Cardiol 2016;68:2733-44. DOI PubMed
91. Forrest JK, Adams DH, Popma JJ, et al. Transcatheter aortic valve replacement in women versus men (from the US CoreValve Trials).
Am J Cardiol 2016;118:396-402. DOI PubMed
92. D'Ascenzo F, Gonella A, Moretti C, et al. Gender differences in patients undergoing TAVI: a multicentre study. EuroIntervention
2013;9:367-72. DOI PubMed
93. Buja P, Napodano M, Tamburino C, et al; Italian Multicenter CoreValve Registry Investigators. Comparison of variables in men
versus women undergoing transcatheter aortic valve implantation for severe aortic stenosis (from Italian Multicenter CoreValve
registry). Am J Cardiol 2013;111:88-93. DOI PubMed
94. Humphries KH, Toggweiler S, Rodés-Cabau J, et al. Sex differences in mortality after transcatheter aortic valve replacement for severe